Acute suppurative parotitis
Acute suppurative parotitis is treated with empiric antibiotics plus optimization of salivary flow, with escalation to imaging and drainage when indicated. [1] Supportive care includes hydration, warm compresses, massage, oral hygiene, and sialagogues. [1] Systemic illness warrants empiric intravenous antibiotics with step-down to oral therapy. [1]
Initial evaluation and triage
Acute suppurative parotitis typically presents with unilateral pain and gland swelling that can progress to fever, trismus, and abscess formation, with purulence potentially expressed from the duct. [1] Computed tomography is the preferred imaging modality for suspected acute sialadenitis, with ultrasonography as an alternative. [1] Clinical features should be used to determine whether presentation is consistent with viral/nonsuppurative disease, obstructive sialadenitis, or malignancy. [1]
Medication selection algorithm
Empiric therapy is selected to cover likely pathogens for acute suppurative parotitis, including Staphylococcus aureus, viridans streptococci, anaerobes, and gram-negative organisms such as Escherichia coli. [1]
- First-line empiric intravenous options (systemic illness or severe presentation):
- Ampicillin/sulbactam 3 g every 6 hours, or [1]
- Ceftriaxone 1 to 2 g daily plus metronidazole 500 mg every 8 hours, or [1]
-
Ceftriaxone plus clindamycin 600 to 900 mg every 8 hours (alternative anaerobe coverage). [1]
-
First-line empiric oral options (mild presentation or no systemic illness):
- Amoxicillin/clavulanate 875 to 125 mg every 12 hours, or [1]
-
Cefuroxime 500 mg every 12 hours (or a macrolide for penicillin allergy) plus metronidazole 500 mg every 8 hours. [1]
-
Empiric coverage for methicillin-resistant Staphylococcus aureus risk factors:
- Vancomycin with dosing adjusted to patient factors, or [1]
-
Linezolid 600 mg every 12 hours. [1]
-
Empiric coverage for Pseudomonas aeruginosa risk factors:
- Piperacillin/tazobactam 3.375 g every 6 hours or 4.5 g every 8 hours, or [1]
- Meropenem 1 g every 8 hours (or other carbapenem). [1]
Treatment initiation thresholds
Patients with systemic signs of illness should receive empiric intravenous antibiotics, followed by oral step-down therapy once clinically improved. [1] Oral antibiotics are appropriate for the absence of systemic illness or for mild cases. [1]
Monotherapy versus combination therapy
Combination antibiotic therapy is used when anaerobic coverage is required with beta-lactam therapy (for example, ceftriaxone plus metronidazole). [1] When penicillin allergy is present, macrolide-containing oral regimens may be used with metronidazole to provide anaerobic coverage. [1] MRSA or Pseudomonas risk factor regimens are treated with the agents listed above rather than adding additional standard anaerobic coverage. [1]
Supportive care measures
Salivary flow should be increased using sialagogues (for example, vitamin C lozenges), hydration, massage, warm compresses, and oral hygiene. [1] Citric acid and malic acid (found in lemons, limes, apples, and grapes) also stimulate salivary flow. [1]
When imaging and procedures are indicated
If an abscess is present, the abscess should be drained, and purulent material should be cultured to guide treatment. [1] Computed tomography should be obtained when acute suppurative sialadenitis requires imaging for assessment or complications, because it is the preferred imaging modality for acute sialadenitis. [1]
Common pitfalls to avoid
Delayed drainage should be avoided when an abscess is present because drainage with culture is recommended to guide therapy. [1] Unnecessary antibiotic treatment should be avoided when presentation is consistent with viral/nonsuppurative sialadenitis, which is treated with supportive care. [1]
Treatment goals
The treatment goals are clinical improvement of pain and inflammation, restoration of adequate salivary flow, and eradication of bacterial pathogens based on empiric therapy and culture-directed therapy when drainage occurs. [1]